Trial intelligence / Profile preview

Azithromycin anti-inflammatory effect in kidney donors and potential effect on recipients

IRCT201606141853N11Phase 3Completed

Sponsor
Urology Research Centre
Start
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of azithromycin in kidney allograft rejection, sponsored by Urology Research Centre. Primary endpoint: Transplanted kidney function. Started Jun 2016; status: completed.

02

Drugs

azithromycin
03

Conditions

kidney allograft rejection

Beyond the preview

Go deeper on IRCT201606141853N11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201606141853N11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call